MENU
ATHE
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Alterity Therapeutics (ATHE) Ownership - Who owns Alterity Therapeutics?
Alterity Therapeutics Ltd is a clinical-stage biotechnology company focused on neurodegenerative diseases and the creation of a chemical library of proprietary molecules... Show more
Industry: #Biotechnology
Profile
Industry
Biotechnology
Address
350 Collins Street
Phone
+61 393494906
Employees
11
Web
https://www.alteritytherapeutics.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
78.93M
P/E Ratio
N/A
Total Cash
40.66M
Projected Growth
N/A
Total Debt
155.46K
Revenue
N/A
Risk (Beta)
0.15
Dividend Yield
N/A
Total Cash/Share
2.24
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
ATHE
Capitalization
78.9M
P/E Ratio
N/A
Risk (Beta)
0.15
Dividend Yield
N/A
Total Cash
40.7M
Total Cash/Share
2.24
Total Debt
155K
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
42.4M
P/B Ratio
2.63
Cash Flow
N/A
Earnings
-1.14
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
263M
Current Ratio
12.98
Current Revenue Per Employee
9166.06
Dividends Per Share - Security
N/A
EBITDA
-12.19M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-37.23
Shares Held By Institutions
864K
Shares Outstanding - Current
18.1M
Total Liabilities
3.62M
Total Volume MTD
N/A
Value
-1
Gain YTD
22.598
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period.
A.I. Advisor
published General Information
General Information
a developer of therapeutic drugs
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
350 Collins Street
Phone
+61 393494906
Employees
11
Web
https://www.alteritytherapeutics.com